Sign in

Daliya Pencheva

@daliyapencheva.bsky.social
19 followers 29 following 4 posts

Rheumatologist, MD, PhD • University Hospital “St. Ivan Rilski” Sofia • EMEUNET Country Liaison 🇧🇬

PostsRepliesMedia
Reposted by Daliya Pencheva
Dr. John Cush @rheumnow.bsky.social · 10/08/2026
Rethinking Treatment of EGPA Like MPA & GPA, the goals of EGPA are to control initial organ damage and prevent relapse. But EGPA has the added challenge of chronic upper and lower respiratory tract involvement, allergic type 2 inflammations and risk of glucocorticoid dependence. buff.ly/tfeFQac
011
Daliya Pencheva @daliyapencheva.bsky.social · 22/06/2026
No rheumatology meeting is complete without EMEUNET! 💜 Happy to represent EMEUNET at Summer Rheumatology Days 2026 🇧🇬, connecting young rheumatologists with opportunities across the #eularEMEUNET network!
010
Reposted by Daliya Pencheva
The European Alliance of Associations for Rheumatology @eular.org · 19/06/2026
✨The European Certificate of Rheumatology is now launched! 📖Developed by EULAR and UEMS, this certification promotes excellence, growth, and high standards in rheumatology. 🎥Learn more about the vision behind this initiative and its impact on the future of rheumatology. #eularEDUCATION
031
Daliya Pencheva @daliyapencheva.bsky.social · 08/06/2026
Wrapping up a fantastic #EULAR2026 in beautiful London 🇬🇧 🥇 EMEUNET Country Liaison Award 📌 SLE poster 📱 Social Media Ambassador 📝 Guest Social Media Editor 🤝 EMEUNET activities & discussions ✨ EULAR Family Dinner & reconnecting with friends #eularEMEUNET
010
Reposted by Daliya Pencheva
Annals of the Rheumatic Diseases @ard.eular.org · 06/06/2026
Can biologics modify the natural course of #SLE? Sessions at #EULAR2026 explored how disease activity monitoring tools and clinical trial design shape treatment evaluation, and whether modern biologics can alter the long-term trajectory of lupus. @daliyapencheva.bsky.social
063
Reposted by Daliya Pencheva
Annals of the Rheumatic Diseases @ard.eular.org · 06/06/2026
Which b/tsDMARD should you choose in #axSpA? An updated overview of the evidence presented at #EULAR2026 highlights differences in efficacy across r-axSpA, nr-axSpA and key extra-musculoskeletal manifestations, helping to inform personalized treatment decisions. @daliyapencheva.bsky.social
032
Reposted by Daliya Pencheva
Annals of the Rheumatic Diseases @ard.eular.org · 05/06/2026
Pregnancy outcomes in RMDs are strongly influenced by disease activity at conception. Early counselling, stable disease, and appropriate treatment planning can improve outcomes for both mother and child Highlights from #EULAR2026 @daliyapencheva.bsky.social
033
Reposted by Daliya Pencheva
ero.eular.org @ero.eular.org · 04/06/2026
​📊 New data from the SPACE cohort evaluates the 2025 ASAS-SPARTAN #axSpA criteria! ​The revised sets prioritise specificity (💥 all >94% regardless of reader). ​📉 However, massive drop-off in sensitivity. For local readers, 83.0% (2009 criteria) down to just 60.2%. #EULAR2026 #OP0239
155
Reposted by Daliya Pencheva
Annals of the Rheumatic Diseases @ard.eular.org · 03/06/2026
021
Reposted by Daliya Pencheva
Annals of the Rheumatic Diseases @ard.eular.org · 03/06/2026
👋🏽 Good morning from London 🇬🇧 We are starting the EULAR 2026 Congress with the EULAR General Assembly. #EULAR2026 @rafaprieto4.bsky.social
053
Reposted by Daliya Pencheva
Annals of the Rheumatic Diseases @ard.eular.org · 02/06/2026
​🎉 Meet the brilliant ARD & ERO Guest Social Media Editors for #EULAR2026! 🚀 ​Say hello to Jelena, Ertuğrul, Mariana, Guillermo, Rúben, Daliya, & Elvis! They’ll be bringing you the best insights straight from the congress.
054
Reposted by Daliya Pencheva
The Lancet Rheumatology @thelancetrheum.bsky.social · 04/02/2026
Since their introduction 20 years ago, GLP-1 receptor agonists have revolu­tionised the treatment of diabetes and obesity. In our Feb editorial we discuss the current data on GLP-1 receptor agonists in rheumatic disease bit.ly/4c4N5Zi #Medsky #Rheumsky
021
Daliya Pencheva @daliyapencheva.bsky.social · 01/02/2026
🔔 EULAR Courses are now open! 🗓 30 May–1 June & 2 June 2026 | London 🇬🇧 MSUS (Basic–Advanced, TTT) & Capillaroscopy with top experts ⏰ Deadlines: 8 Mar / 31 Mar 2026 💡 Bursaries | ⚡ Limited places 🔗 edu.eular.org #EULAR #Rheumatology #MSUS #Capillaroscopy #RMDs
edu.eular.org
EULAR Education
010
Daliya Pencheva @daliyapencheva.bsky.social · 25/01/2026
⏰ 1 WEEK LEFT! Apply for the 2026–2027 #SLEuroSociety Mentorship Programme, supported by #LupusResearchAlliance 🗓️ Deadline: 30 Jan 2026 🎓 A fantastic opportunity for young rheumatologists - highly recommended! ✨ 🔗 sleuro.org/the-program/
sleuro.org
The Program – SLEuro
021
Reposted by Daliya Pencheva
The European Alliance of Associations for Rheumatology @eular.org · 05/01/2026
📢 Deadline is fast approaching for Abstract and Case Report submissions! Don't miss the opportunity to present your ground-breaking research at the EULAR Congress in London, UK. 🔗 Submit yours before 15 January 2026 here: pulse.ly/n9bheg2qxh #EULAR2026 #Rheumatology
042
Reposted by Daliya Pencheva
The European Alliance of Associations for Rheumatology @eular.org · 23/05/2025
🌟Young rheumatologists, this one’s for you! Join us at #EULAR2025 in Barcelona and meet the EMEUNET community! ⚡Research Speed Dating. 🎓Mentor-Mentee Meetings & Career Guidance. 🌍Global networking & RheumaVision finals. For more information👉https://pulse.ly/bsxohrydp3 #eularEMEUNET #Rheumatology
042